PNAA
AMED

Pictet North America Advisors’s Amedisys AMED Stock Holding History

Pictet North America Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-15,679
Closed -$1.52M – 133
2022
Q3 		$1.52M Sell
15,679
-1,006
-6% -$120K 0.24% 61
2022
Q2 		$1.75M Sell
16,685
-1,048
-6% -$134K 0.23% 62
2022
Q1 		$3.06M Sell
17,733
-2,138
-11% -$319K 0.35% 49
2021
Q4 		$3.22M Buy
19,871
+5,402
+37% +$868K 0.32% 48
2021
Q3 		$2.16M Buy
+14,469
New +$3.01M 0.21% 59

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Pictet North America Advisors's AMED Position: Q4 2022 in Review

Pictet North America Advisors sold out of Amedisys (AMED) in Q4 2022, closing a stake of 15,679 shares — an estimated $1.52M sold.

Pictet North America Advisors first reported a position in AMED in Q3 2021 and held it in 5 quarters. The position peaked at $3.22M in Q4 2021. 278 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Pictet North America Advisors reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Pictet North America Advisors sold 15,679 Amedisys shares in Q4 2022, an estimated $1.52M.
  • Pictet North America Advisors first reported a position in Amedisys in Q3 2021 and held it in 5 quarters.
  • Pictet North America Advisors's Amedisys position peaked at $3.22M in Q4 2021.
  • 278 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Pictet North America Advisors's 13F filing for Q4 2022, filed 22 Mar 2023.